MX2019013154A - Vacuna contra la enfermedad respiratoria bovina. - Google Patents

Vacuna contra la enfermedad respiratoria bovina.

Info

Publication number
MX2019013154A
MX2019013154A MX2019013154A MX2019013154A MX2019013154A MX 2019013154 A MX2019013154 A MX 2019013154A MX 2019013154 A MX2019013154 A MX 2019013154A MX 2019013154 A MX2019013154 A MX 2019013154A MX 2019013154 A MX2019013154 A MX 2019013154A
Authority
MX
Mexico
Prior art keywords
bovine respiratory
respiratory disease
vaccines
bovine
disease vaccine
Prior art date
Application number
MX2019013154A
Other languages
English (en)
Inventor
Halbur Thomas
Huntimer Lucas
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of MX2019013154A publication Critical patent/MX2019013154A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a vacunas para tratar la enfermedad respiratoria bovina. Dichas vacunas contienen una combinación de virus de la influenza D bovina y antígenos de Mannheimia haemolytica. Una infección de las vías respiratorias superiores con un IDV conduce a un mayor potencial para la patología de M. haemolytica en los pulmones. Las vacunas pueden contener antígenos adicionales de otros patógenos respiratorios bovinos.
MX2019013154A 2017-05-05 2018-04-27 Vacuna contra la enfermedad respiratoria bovina. MX2019013154A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762502004P 2017-05-05 2017-05-05
PCT/US2018/029759 WO2018204178A1 (en) 2017-05-05 2018-04-27 Bovine respiratory disease vaccine

Publications (1)

Publication Number Publication Date
MX2019013154A true MX2019013154A (es) 2020-02-05

Family

ID=62165675

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013154A MX2019013154A (es) 2017-05-05 2018-04-27 Vacuna contra la enfermedad respiratoria bovina.

Country Status (12)

Country Link
US (1) US11439701B2 (es)
EP (1) EP3618858A1 (es)
JP (2) JP7341120B2 (es)
CN (1) CN110545839A (es)
AR (1) AR111770A1 (es)
AU (1) AU2018262481B2 (es)
BR (1) BR112019020635A2 (es)
CA (1) CA3060122A1 (es)
MX (1) MX2019013154A (es)
NZ (1) NZ757651A (es)
RU (1) RU2762938C2 (es)
WO (1) WO2018204178A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020102366A1 (en) * 2018-11-14 2020-05-22 The Regents Of The University Of California Methods of determining the risk of bovine respiratory disease in pre-weaned dairy calves
CN113552191B (zh) * 2021-07-28 2023-11-21 江苏师范大学 基于多层dna放大回路检测甲基化dna的比例型电化学传感器的构建方法
CN116785420B (zh) * 2023-08-21 2023-11-14 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种牛病毒性腹泻病毒的mRNA疫苗及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2587084C (en) 2004-10-08 2019-07-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Modulation of replicative fitness by using less frequently used synonym ous codons
EP4368202A2 (en) 2007-03-30 2024-05-15 The Research Foundation for The State University of New York Attenuated viruses useful for vaccines
RU2403061C1 (ru) * 2009-06-29 2010-11-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина инактивированная комбинированная против инфекционного ринотрахеита, парагриппа-3, респираторно-синцитиальной болезни, вирусной диареи и пастереллеза крупного рогатого скота
TWI396547B (zh) * 2009-09-02 2013-05-21 Univ Nat Pingtung Sci & Tech 溶血性曼哈米亞桿菌疫苗
US9278999B2 (en) 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
MX2015000789A (es) 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
US10316294B2 (en) 2013-03-15 2019-06-11 The Research Foundation For The State University Of New York Attenuated influenza viruses and vaccines
US20180326040A1 (en) 2015-11-16 2018-11-15 Kansas State University Research Foundation Influenza virus vaccine and vaccine platform

Also Published As

Publication number Publication date
US20210338799A1 (en) 2021-11-04
JP2020516691A (ja) 2020-06-11
CN110545839A (zh) 2019-12-06
BR112019020635A2 (pt) 2020-04-22
AR111770A1 (es) 2019-08-21
RU2019132984A (ru) 2021-06-07
EP3618858A1 (en) 2020-03-11
CA3060122A1 (en) 2018-11-08
AU2018262481A1 (en) 2019-10-17
NZ757651A (en) 2022-07-01
WO2018204178A1 (en) 2018-11-08
JP7341120B2 (ja) 2023-09-08
RU2019132984A3 (es) 2021-06-07
US11439701B2 (en) 2022-09-13
JP2022070898A (ja) 2022-05-13
AU2018262481B2 (en) 2021-07-29
RU2762938C2 (ru) 2021-12-24

Similar Documents

Publication Publication Date Title
MX2023013140A (es) Vacunas contra el virus de la hepatitis b.
MX2016012845A (es) Vacuna contra el virus de la diarrea epidemica porcina.
PH12019500854A1 (en) Recombinant vectors expressing antigens of avian influenza virus and uses thereof
MA40765B1 (fr) Méthodes et compositions d'induction d'une immunité protectrice contre l'infection par le virus de l'immunodéficience humaine
PH12019501766A1 (en) Porcine coronavirus vaccines
PH12020500080A1 (en) Senecavirus a immunogenic compositions and methods thereof
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
EA201300135A1 (ru) Комбинированная фармацевтическая композиция и способы лечения и профилактики инфекционных заболеваний
MX2019013154A (es) Vacuna contra la enfermedad respiratoria bovina.
MX2015016627A (es) Vacuna para la malaria.
GB202104898D0 (en) CpG-adjuvanted SARS-CoV-2 virus vaccine
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
HUE061972T2 (hu) Vakcina sertés parvovirus és sertés reprodukciós és légzõszervi szindróma vírus ellen, és eljárások ezek elõállítására
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
EA201792512A1 (ru) Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
PH12018502436A1 (en) Multivalent vaccines major swine viral diseases
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
MX2019007924A (es) Vacunas contra la influenza.
WO2018066999A3 (en) Chimeric enterovirus virus-like particles
EA202090236A1 (ru) Иммуногенные композиции senecavirus a и способы с ними
ZA202209826B (en) Inactivated sars-cov-2 virus vaccine